Best Momentum Stocks to Buy for July 12th

In this article:

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 12th:

Capital City Bank Group, Inc. CCBG: This financial holding company for Capital City Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.

Capital City Bank Group Price and Consensus

Capital City Bank Group Price and Consensus
Capital City Bank Group Price and Consensus

Capital City Bank Group price-consensus-chart | Capital City Bank Group Quote

Capital City’ shares gained 11.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of B.

Capital City Bank Group Price

Capital City Bank Group Price
Capital City Bank Group Price

Capital City Bank Group price | Capital City Bank Group Quote

Immunocore Holdings plc IMCR: This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.4% over the last 60 days.

Immunocore Holdings PLC Sponsored ADR Price and Consensus

Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR Price and Consensus

Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote

Immunocore’s shares gained 12.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.

Immunocore Holdings PLC Sponsored ADR Price

Immunocore Holdings PLC Sponsored ADR Price
Immunocore Holdings PLC Sponsored ADR Price

Immunocore Holdings PLC Sponsored ADR price | Immunocore Holdings PLC Sponsored ADR Quote

F-star Therapeutics, Inc. FSTX: This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.

Fstar Therapeutics, Inc. Price and Consensus

Fstar Therapeutics, Inc. Price and Consensus
Fstar Therapeutics, Inc. Price and Consensus

Fstar Therapeutics, Inc. price-consensus-chart | Fstar Therapeutics, Inc. Quote

F-star’s shares gained 86.8% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.

Fstar Therapeutics, Inc. Price

Fstar Therapeutics, Inc. Price
Fstar Therapeutics, Inc. Price

Fstar Therapeutics, Inc. price | Fstar Therapeutics, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Capital City Bank Group (CCBG) : Free Stock Analysis Report
 
Fstar Therapeutics, Inc. (FSTX) : Free Stock Analysis Report
 
Immunocore Holdings PLC Sponsored ADR (IMCR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement